Department of Preventive Medicine, Public Health, Immunology and Medical Microbiology, Rey Juan Carlos University, Madrid, Spain.
Chemosphere. 2011 Feb;82(7):1062-71. doi: 10.1016/j.chemosphere.2010.10.041. Epub 2010 Nov 26.
Interest in the presence of pharmaceuticals in wastewater, in the water of our rivers and, to a lesser extent, in our drinking water, has been growing in recent decades. Many of these substances, currently classified as "emerging pollutants", are biologically active compounds and continuously released in effluents. As sewage treatment plants (STPs) are not adequately equipped to eliminate all of these substances completely, some are discharged directly into rivers. In Spain, as in most of its neighbouring countries, there is an elevated use of pharmaceuticals for the treatment of cardiovascular diseases (which are extremely prevalent among the older adult population) and anti-inflammatory medications, which are obtainable over the counter without a medical prescription. This study therefore sought to determine to what degree pharmaceuticals with the highest regional prescription and/or use rates, such as cardiovascular and analgesic/anti-inflammatory/antipyretic medications, were present in the principal rivers (Jarama, Manzanares, Guadarrama, Henares and Tagus) and tap-water samples of the Madrid Region (MR). Samples were taken downstream the discharge of 10 of the most important region's STPs and the most frequently used drugs in the region were analysed for. Of the 24 drugs analysed, 21 were detected at concentrations ranging from 2 ng L⁻¹ to 18 μg L⁻¹. The highest drug concentrations corresponded to ibuprofen, diclofenac, naproxen, atenolol, frusemide (furosemide), gemfibrozil and hydrochlorthiazide, and in most cases exceeded the amounts reported in the scientific literature. No traces of these groups of pharmaceuticals were detected in the drinking water analysed. On the basis of the high concentrations detected, we believe that an environmental surveillance system should be implemented to assess the continuous discharge of these pharmaceuticals and their possible ecotoxicological effects. At the same time, efforts to raise the awareness of the public about responsible use and the proper disposal of such substances at purpose-designated collection points should be increased. Furthermore sewage treatment processes should be suitably adapted to increase the rates of removal of these drugs.
近几十年来,人们对污水、河流乃至饮用水中存在的药物越来越感兴趣。这些物质中的许多目前被归类为“新兴污染物”,是具有生物活性的化合物,并且不断从废水中释放出来。由于污水处理厂 (STP) 没有足够的设备完全消除所有这些物质,因此一些物质会直接排放到河流中。在西班牙,与大多数邻国一样,用于治疗心血管疾病(在老年人群中极为普遍)和抗炎药物的药物使用量很高,这些药物无需处方即可在柜台购买。因此,本研究旨在确定具有最高区域处方和/或使用率的药物(如心血管药物和镇痛药/抗炎药/退烧药)在主要河流(Jarama、Manzanares、Guadarrama、Henares 和 Tagus)和马德里地区自来水中的存在程度(MR)。在 10 个最重要的地区 STP 的排放下游处采集了样本,并对该地区最常用的药物进行了分析。在所分析的 24 种药物中,有 21 种药物的浓度在 2ng/L 至 18μg/L 之间。最高的药物浓度对应于布洛芬、双氯芬酸、萘普生、阿替洛尔、呋塞米(速尿)、吉非贝齐和氢氯噻嗪,而且在大多数情况下,其浓度都超过了文献中的报道。在所分析的饮用水中没有检测到这些药物组的痕迹。基于检测到的高浓度,我们认为应该实施环境监测系统,以评估这些药物的持续排放及其可能的生态毒性影响。同时,应该加强提高公众对负责任使用和在指定收集点妥善处理这些物质的意识。此外,应适当调整污水处理工艺,以提高这些药物的去除率。